| 标题 |
A Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination With Anti-PD-1/L1 in Patients With Locally Advanced or Metastatic Solid Tumors 一项1/2a期研究,旨在评价Alpha Kinase 1(ALPK 1)激活剂PT-936单独或与抗PD-1/L1联合治疗局部晚期或转移性实体瘤患者的安全性、药代动力学和有效性
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)